Autopsy-proven demyelination associated with infliximab treatment.

MLA

Bradshaw, Michael J., et al. “Autopsy-Proven Demyelination Associated with Infliximab Treatment.” Neurology(R) Neuroimmunology & Neuroinflammation, vol. 3, no. 2, Jan. 2016, p. e205. EBSCOhost, https://doi.org/10.1212/NXI.0000000000000205.

APA

Bradshaw, M. J., Mobley, B. C., Zwerner, J. P., & Sriram, S. (2016). Autopsy-proven demyelination associated with infliximab treatment. Neurology(R) Neuroimmunology & Neuroinflammation, 3(2), e205. https://doi.org/10.1212/NXI.0000000000000205

Chicago

Bradshaw, Michael J, Bret C Mobley, Jeffrey P Zwerner, and Subramaniam Sriram. 2016. “Autopsy-Proven Demyelination Associated with Infliximab Treatment.” Neurology(R) Neuroimmunology & Neuroinflammation 3 (2): e205. doi:10.1212/NXI.0000000000000205.